These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 15277046

  • 1. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps.
    Seto H, Suzaki H, Shioda S.
    Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
    Shin SH, Park JY, Jeon CH, Choi JK, Lee SH.
    Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
    [Abstract] [Full Text] [Related]

  • 3. [The role of chemokines in nasal polyps].
    Caversaccio M, Hartnell A, Calnan D, Jose P, Mackay IS, Uguccioni M, Baggiolini M, Williams TJ, Conroy DM.
    Schweiz Med Wochenschr; 2000 Aug; Suppl 125():92S-95S. PubMed ID: 11141953
    [Abstract] [Full Text] [Related]

  • 4. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
    Olze H, Förster U, Zuberbier T, Morawietz L, Luger EO.
    Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
    [Abstract] [Full Text] [Related]

  • 5. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
    Yao T, Kojima Y, Koyanagi A, Yokoi H, Saito T, Kawano K, Furukawa M, Kusunoki T, Ikeda K.
    Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
    [Abstract] [Full Text] [Related]

  • 6. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression.
    Bartels J, Maune S, Meyer JE, Kulke R, Schlüter C, Röwert J, Christophers E, Schröder JM.
    Rhinology; 1997 Dec; 35(4):171-4. PubMed ID: 9532637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of nasal polyp epithelial cells on eosinophil activation.
    Shin SH, Lee SH, Jeong HS, Kita H.
    Laryngoscope; 2003 Aug; 113(8):1374-7. PubMed ID: 12897562
    [Abstract] [Full Text] [Related]

  • 10. [Expression and clinical significance of Eotaxin-3 in chronic rhinosinusitis with and without nasal polyps].
    Liu M, Zhao H, Cao Z.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(3):190-3. PubMed ID: 27373085
    [Abstract] [Full Text] [Related]

  • 11. Eosinophil infiltration and activation in nasal polyposis.
    Fan GK, Wang H, Takenaka H.
    Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
    [Abstract] [Full Text] [Related]

  • 12. Clinical factors influencing the eosinophil infiltration of nasal polyps.
    Jankowski R, Bouchoua F, Coffinet L, Vignaud JM.
    Rhinology; 2002 Dec; 40(4):173-8. PubMed ID: 12526243
    [Abstract] [Full Text] [Related]

  • 13. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.
    Saito H, Honda K, Asaka C, Ueki S, Ishikawa K.
    Allergol Int; 2016 Jul; 65(3):280-5. PubMed ID: 26874579
    [Abstract] [Full Text] [Related]

  • 14. Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.
    Hyo S, Kawata R, Kadoyama K, Eguchi N, Kubota T, Takenaka H, Urade Y.
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):693-700. PubMed ID: 17638783
    [Abstract] [Full Text] [Related]

  • 15. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, Onoda J, Yokoi H, Ikeda K.
    Int Arch Allergy Immunol; 2010 Jul; 151(1):8-16. PubMed ID: 19672092
    [Abstract] [Full Text] [Related]

  • 16. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis.
    Fujiwara H, Morita A, Kobayashi H, Hamano K, Fujiwara Y, Hirai K, Yano M, Naka T, Saeki Y.
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):429-32. PubMed ID: 12392390
    [Abstract] [Full Text] [Related]

  • 17. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.
    Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, Rothenberg M, Luster AD, Hamid Q.
    Am J Respir Cell Mol Biol; 1997 Dec; 17(6):683-90. PubMed ID: 9409555
    [Abstract] [Full Text] [Related]

  • 18. Bronchial interleukin-5 and eotaxin expression in nasal polyposis. Relationship with (a)symptomatic bronchial hyperresponsiveness.
    Lamblin C, Bolard F, Gosset P, Tsicopoulos A, Perez T, Darras J, Janin A, Tonnel AB, Hamid Q, Wallaert B.
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1226-32. PubMed ID: 11316663
    [Abstract] [Full Text] [Related]

  • 19. Intracellular localization and release of eotaxin from normal eosinophils.
    Nakajima T, Yamada H, Iikura M, Miyamasu M, Izumi S, Shida H, Ohta K, Imai T, Yoshie O, Mochizuki M, Schröder JM, Morita Y, Yamamoto K, Hirai K.
    FEBS Lett; 1998 Sep 04; 434(3):226-30. PubMed ID: 9742928
    [Abstract] [Full Text] [Related]

  • 20. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
    Schratl P, Sturm EM, Royer JF, Sturm GJ, Lippe IT, Peskar BA, Heinemann A.
    Eur J Immunol; 2006 Sep 04; 36(9):2401-9. PubMed ID: 16906532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.